Early detection of breast cancer
The CA 15.3 test is not used to diagnose breast cancer, but it can be used to monitor the treatment of breast cancer in women who have already been diagnosed. Regular CA 15.3 tests can help detect any changes in the cancer and allow for early intervention, improving the chances of a positive outcome.
Effective treatment monitoring
The CA 15.3 test can help healthcare providers monitor the treatment of breast cancer. Elevated CA 15.3 levels may indicate that the cancer is progressing or that the treatment is not effective, allowing healthcare providers to adjust the treatment plan and improve the chances of a positive outcome.
Assessing cancer recurrence
The CA 15.3 test can also be used to assess the risk of cancer recurrence. Elevated CA 15.3 levels may indicate that the cancer has returned, and further tests may be needed to confirm the diagnosis.
In conclusion, the CA 15.3 test is an important tool in the monitoring and management of breast cancer. It measures the level of the cancer antigen 15-3 protein in the blood, which is produced by some breast cancer cells. The test is used to monitor treatment effectiveness and assess the risk of recurrence. The procedure is quick, simple, and painless, and normal levels of CA 15.3 vary based on the laboratory and the patient's age, sex, and overall health. Elevated levels of CA 15.3 can indicate the presence of breast cancer or the risk of recurrence, but further tests may be needed to confirm the diagnosis. Regular CA 15.3 tests can help detect changes in the cancer and allow for early intervention, improving the chances of a positive outcome.